Carregant...
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi
Guardat en:
Publicat a: | Haematologica |
---|---|
Autors principals: | , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Ferrata Storti Foundation
2016
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5004354/ https://ncbi.nlm.nih.gov/pubmed/26858355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.139329 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|